News
}
Viva Biotech Attended T20 BIO TONACEA Conference to Shape the Future of Pharmaceutical Innovation
Time: 2024-07-29
Source: Viva Biotech
Share:
[Abstract]:Viva Biotech demonstrated its comprehensive capabilities, empowering innovative drug R&D through multiple core technology platforms.

The T20 BIO TONACEA Conference grandly opened at the Kempinski Hotel Suzhou, bringing together numerous experts and scholars from the industry. Participants gathered to discuss the theme of "The Future of Pharmaceutical Innovation in China," exploring cutting-edge technologies, industry trends, and shared experiences in the field of biopharmaceuticals.

 

Viva Biotech was invited to participate in this exhibition, showcasing the company's one-stop CRO/CDMO service capabilities. Additionally, Dr. Han Dai, Chief Innovation Officer (CIO) of Viva Biotech and Head of the Viva BioInnovatior, was invited as a special guest and chaired a roundtable discussion titled "The Opportunities and Limitations of Upstream Pharmaceutical Research". Dr. Dai delved into topics as the development potential, technical bottlenecks, and innovative opportunities in the upstream sector of new drug R&D with other industry experts such, providing attendees with comprehensive and profound industry insights.

 

First from left: Dr. Han Dai, CIO of Viva Biotech and Head of Viva BioInnovator

 

 

During the exhibition, the Viva Biotech’s team warmly welcomed guests at the booth, sharing in-depth insights and successful experiences in new drug development and manufacturing. The team showcased a range of cutting-edge technology platforms, including the XDC platform, PROTAC/molecular glue technology platform, protein production and structural research, membrane protein research, cryo-EM, drug screening, Bioassays, DMPK, AIDD/CADD, and therapeutic antibody discovery on booth. These platforms highlighted the company's innovative capabilities in biopharmaceutical R&D. Faced with a diverse range of R&D inquiries from booth visitors, Viva Biotech's expert team delivered not only highly targeted and practical solutions but also actively engaged in discussion about groundbreaking research ideas, collectively pushing the boundaries of innovation. The team's technical prowess and innovative concepts garnered significant praise from attendees. We anticipate future industry events, where we can collaborate with more partners to explore emerging trends and drive advancements in global pharmaceutical innovation.
 

Media contact: vivapr@vivabiotech.com
Contact Us